Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/edAqCfbwoceXjdvlHtyI

  ADVERTISEMENT  
December 31, 2012News for the transfusion medicine and cellular therapy community

  Top Story 
  ADVERTISEMENT  
Clinical Research: Understanding the Methodology Toolbox
Clinical Research: Understanding the Methodology Toolbox compiles articles of evidence-based research for use as an educational resource for those involved in clinical research, healthcare professionals and trainees in transfusion medicine and other medical specialties. Now in the AABB Marketplace.

  Science & Health 
  • CDC: 150,000 patients exposed to unsafe injections
    More than 150,000 patients have received unsafe injections since 2001, with two-thirds of reported cases coming in the past four years, according to data from the CDC. "The lack of oversight in non-hospital settings is a big gap in the regulatory environment," said Evelyn McKnight, who contracted hepatitis at an oncology clinic and now leads the HONOReform foundation, an advocate for safe injections. USA Today (12/28) LinkedInFacebookTwitterEmail this Story
  • Researchers find MRSA strain in U.K. milk
    Researchers discovered MRSA ST398, a strain of methicillin-resistant Staphylococcus aureus, in samples of milk in the U.K. Consumers of pasteurized milk are not at risk of infection, but veterinarians and workers at farms and slaughterhouses could be infected and spread the illness, experts said. United Press International (12/29) LinkedInFacebookTwitterEmail this Story
  Hot Topics 

Top five news stories selected by AABB SmartBrief readers in the past week.

  • Results based on number of times each story was clicked by readers.
  Emerging Trends 
  • Misuse and overuse of ambulatory care remain steady, study finds
    Overuse and misuse of ambulatory care largely remained steady from 1998-99 to 2008-09 despite the discussion of spiraling health care costs, according to a study in the Archives of Internal Medicine. Researcher Dr. Minal S. Kale said the results suggest policymakers have focused more on issues of underuse than overuse. Kale and co-authors call for the development of performance measures to limit the delivery of inappropriate care and clinical practice guidelines covering unnecessary care. Reuters (12/24), Medscape (free registration) (12/24) LinkedInFacebookTwitterEmail this Story
  Industry News & Practice 
  Government & Regulatory 
  • FDA has 2014 deadline for social media rules
    The FDA is directed to create social media rules by summer 2014 under a provision in a bill passed this summer, said Brian Reid, a director at communications firm WCG. The provision opens up several possibilities: the development of a comprehensive guidance document, congressional hearings if the FDA misses the deadline and small rule changes that integrate rather than separate social media guidance. Pharmalot.com/Pharma Blog (12/27) LinkedInFacebookTwitterEmail this Story
 
  • Coaxia's NeuroFlo catheter undergoes FDA panel review
    An FDA panel recently met to consider CoAxia's de novo application for use of its NeuroFlo catheter within 14 hours after symptoms begin to show in ischemic stroke patients who aren't fit to receive thrombectomy or tissue plasminogen activator. The device, which already has 510(k) clearance, is used to control or halt the flow of blood in peripheral vessels. Medscape (free registration) (12/28) LinkedInFacebookTwitterEmail this Story
  Association News 
  • AABB requests nominations for 2013, 2014 memorial awards
    AABB is seeking nominations for its 2013 and 2014 memorial awards, which will honor individuals who have advanced the practice of transfusion medicine and cellular therapies. The awards are presented to recognize achievements in administration, immunohematology, quality and innovative research, and overall outstanding service. Individuals are encouraged to nominate candidates by completing and submitting the online nomination form by Jan. 25. Recipients will be honored at the 2013 AABB Annual Meeting in Denver or the 2014 AABB Annual Meeting in Philadelphia. LinkedInFacebookTwitterEmail this Story
Learn more about AABB® ->Homepage  |  Join AABB  |  Conferences  |  Marketplace

  Editor's Note 
  • SmartBrief will not publish Tuesday
    In observance of New Year's Day, SmartBrief will not publish Tuesday. Publication will resume Wednesday. Enjoy the holiday! LinkedInFacebookTwitterEmail this Story
Position TitleCompany NameLocation
Performance Improvement ConsultantBlood Systems, Inc.US - AZ - Scottsdale
LABORATORY MANAGERUnited Blood ServicesUS - NV - Las Vegas
DIRECTOR, COMMUNITY CENTER IUnited Blood ServicesUS - NV - Reno
QA SpecialistSan Diego Blood BankUS - CA
Reference TechnologistLifeStreamUS - CA - San Bernardino
West Coast Account ManagerMacopharma USAUS - Nationwide
Click here to view more job listings.

  SmartQuote 
Never tell your resolution beforehand, or it's twice as onerous a duty."
--John Selden,
English jurist and scholar


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Corporate Relations Manager:  Tamara Zein (240) 333-6604
Job Board: AABB CareerLink
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent AABB SmartBrief Issues:   Lead Editor:  Tom Parks
Managing Editor: Cristian Becker

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.® Legal Information